Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Gastric Cancer

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 25 articles:
HTML format



Single Articles


    July 2024
  1. LIU X, Chen B, Xie F, Wong KY, et al
    FOXP4 is a Direct YAP1 Target that Promotes Gastric Cancer Stemness and Drives Metastasis.
    Cancer Res. 2024 Jul 24. doi: 10.1158/0008-5472.CAN-23-3074.
    PubMed     Abstract available


  2. LIU S, Lin C, Lin X, Lin P, et al
    NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression.
    Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-23-4062.
    PubMed     Abstract available


  3. GNANAPRAGASAM A, Kirbizakis E, Li A, White KH, et al
    HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer.
    Cancer Res. 2024;84:2377-2389.
    PubMed     Abstract available


    December 2023
  4. TU RH, Wu SZ, Huang ZN, Zhong Q, et al
    Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer.
    Cancer Res. 2023;83:3868-3885.
    PubMed     Abstract available


    September 2023
  5. FAN Y, Song S, Li Y, Dhar SS, et al
    Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T cell Immunity in Gastric Cancer Peritoneal Metastases.
    Cancer Res. 2023 Sep 22. doi: 10.1158/0008-5472.CAN-23-0783.
    PubMed     Abstract available


    August 2023
  6. YE H, Shi W, Yang J, Wang L, et al
    PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
    Cancer Res. 2023 Aug 30. doi: 10.1158/0008-5472.CAN-23-1331.
    PubMed     Abstract available


    May 2023
  7. PETRELLI A, Rizzolio S, Pietrantonio F, Bellomo SE, et al
    BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
    Cancer Res. 2023 May 2:OF1-OF12. doi: 10.1158/0008-5472.CAN-22-2620.
    PubMed     Abstract available


    March 2023
  8. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
    Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
    Cancer Res. 2023;83:804.
    PubMed    


  9. TAURIELLO DVF
    Targeting CAFs to Improve Anti-PD-1 Checkpoint Immunotherapy.
    Cancer Res. 2023;83:655-656.
    PubMed     Abstract available


  10. AKIYAMA T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, et al
    Stromal Reprogramming through Dual PDGFRalpha/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
    Cancer Res. 2023;83:753-770.
    PubMed     Abstract available


    December 2022
  11. SHEN Y, Zhang N, Chai J, Wang T, et al
    CircPDIA4 induces gastric cancer progression by promoting ERK1/2 activation and enhancing biogenesis of oncogenic circRNAs.
    Cancer Res. 2022 Dec 23:CAN-22-1923. doi: 10.1158/0008-5472.CAN-22-1923.
    PubMed     Abstract available


    November 2022
  12. LLORCA-CARDENOSA MJ, Aronson LI, Krastev DB, Nieminuszczy J, et al
    SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance.
    Cancer Res. 2022;82:3962-3973.
    PubMed     Abstract available


  13. O'LEARY PC, Chen H, Doruk YU, Williamson T, et al
    Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2.
    Cancer Res. 2022;82:3950-3961.
    PubMed     Abstract available


    May 2022
  14. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
    Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
    Cancer Res. 2022 May 18. pii: 699013. doi: 10.1158/0008-5472.CAN-21-2072.
    PubMed     Abstract available


  15. KUMAGAI K, Shimizu T, Takai A, Kakiuchi N, et al
    Expansion of Gastric Intestinal Metaplasia with Copy Number Aberrations Contributes to Field Cancerization.
    Cancer Res. 2022;82:1712-1723.
    PubMed     Abstract available


    March 2022
  16. DUAN X, Chen H, Zhou X, Liu P, et al
    EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.
    Cancer Res. 2022;82:1070-1083.
    PubMed     Abstract available


  17. WANG J, Huang Q, Hu X, Zhang S, et al
    Disrupting circadian rhythm via the PER1-HK2 axis reverses trastuzumab resistance in gastric cancer.
    Cancer Res. 2022 Mar 7. pii: 682075. doi: 10.1158/0008-5472.CAN-21-1820.
    PubMed     Abstract available


    December 2021
  18. JUN Y, Suh YS, Park S, Lee J, et al
    Comprehensive analysis of alternative splicing in gastric cancer identifies epithelial-mesenchymal transition subtypes associated with survival.
    Cancer Res. 2021 Dec 13. pii: 0008-5472.CAN-21-2117.
    PubMed     Abstract available


    August 2021
  19. VAN DONGEN GAMS
    Improving Tumor Penetration of Antibodies and Antibody-Drug Conjugates: Taking Away the Barriers for Trojan Horses.
    Cancer Res. 2021;81:3956-3957.
    PubMed     Abstract available


    February 2021
  20. AN O, Song Y, Ke X, So JB, et al
    "3G" Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy.
    Cancer Res. 2021 Feb 8. pii: 0008-5472.CAN-20-2872.
    PubMed     Abstract available


  21. GRUNBERG N, Pevsner-Fischer M, Goshen-Lago T, Diment J, et al
    Cancer-associated fibroblasts promote aggressive gastric cancer phenotypes via heat shock factor 1-mediated secretion of extracellular vesicles.
    Cancer Res. 2021 Feb 5. pii: 0008-5472.CAN-20-2756.
    PubMed     Abstract available


    December 2020
  22. WU S, Chen M, Huang J, Zhang F, et al
    ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis Through PI3K/Akt Signaling and MAPK-dependent Focal Adhesion Disassembly.
    Cancer Res. 2020 Dec 11. pii: 0008-5472.CAN-20-0049.
    PubMed     Abstract available


    November 2020
  23. SOOTOME H, Fujita H, Ito K, Ochiiwa H, et al
    Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.
    Cancer Res. 2020;80:4986-4997.
    PubMed     Abstract available


    August 2020
  24. UCHIHARA T, Miyake K, Yonemura A, Komohara Y, et al
    Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing beta1 Integrin, Enhancing Drug Resistance.
    Cancer Res. 2020;80:3222-3235.
    PubMed     Abstract available


    June 2020
  25. WANG SC, Yeu Y, Hammer STG, Xiao S, et al
    Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants.
    Cancer Res. 2020;80:2114-2124.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.